ScholarIQanswers from OpenAlex

Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial

PaperCitations, authors & open-access status

Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial have?

ScholarIQcitation count

Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial has 29 citations in the OpenAlex counts ScholarIQ stores.

When was Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial published?

ScholarIQyear

Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial has 2021 year in the ScholarIQ index.

What is the open-access status of Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial?

ScholarIQoa status

Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial has closed oa status in the ScholarIQ index.

What is the DOI of Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial?

ScholarIQdoi

The DOI for Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial is on the source record.

What is the PMID of Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial?

ScholarIQpmid

The PMID for Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial is on the source record.

What is the OpenAlex record for Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial?

ScholarIQopenalex

The OpenAlex for Photobiomodulation therapy is not better than placebo in patients with chronic nonspecific low back pain: a randomised placebo-controlled trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial